For decades, methotrexate has stood as a frontline defense against the joint destruction of rheumatoid arthritis. Now, a study from Flinders University suggests the drug carries a quieter gift: a meaningful reduction in blood pressure that may shield the heart from attack and stroke. In a population already burdened by elevated cardiovascular risk, the discovery that a familiar medicine works on two fronts at once invites a deeper reckoning with how well we truly understand the tools we have long relied upon.
Medical Xpress
· Sep 03, 2025
· health
· 3 min de leitura
High
Apuração: Verificado
Arthritis drug methotrexate shown to lower blood pressure and heart disease risk
◉
Health & Medicine
8358 artigos relacionados
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% correspondência
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% correspondência
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% correspondência
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% correspondência
Cobertura Relacionada
The Guardian · Aug 24
UK approves daily GLP-1 pill for diabetes and weight loss amid counterfeit drug warnings
Foundayo, a new daily pill treating diabetes and aiding weight loss, launches in UK pharmacies Monday. Pharmacists welco…
Mirage News · Aug 24 Study reveals type 2 diabetes in lean Africans requires different treatment approachResearch reveals type 2 diabetes in lean Africans stems from insulin deficiency, not resistance, yet they receive the sa…
Mirage News · Aug 24 Australian researchers identify existing drugs to slow rare childhood dementiaAustralian researchers identified nine existing TGA-approved medicines that could slow brain damage in children with San…
The New Indian Express · Aug 24 Odisha leads national push to prevent metabolic liver disease affecting 1 in 3 IndiansLeading gastroenterology and hepatology experts convened in Odisha to finalize national guidelines for preventing metabo…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Medical research on arthritis drug efficacy has no geopolitical implications; this is a clinical pharmacology study with no international relations, conflict, or power dynamics.
Escalation Risk
low
Confidence
HIGH
Lente Econômica
📈
Methotrexate, an arthritis drug, demonstrates cardiovascular benefits by lowering blood pressure and reducing heart disease risk, potentially expanding its therapeutic value beyond rheumatoid arthritis treatment.
Market Signal
bullish
Confidence
MED
Pharmaceutical/Biotechnology
Healthcare Services
Medical Devices
Insurance (Health)
Patients with rheumatoid arthritis may benefit from reduced medication burden and lower cardiovascular disease risk, potentially decreasing overall healthcare costs. Consumers could see improved health outcomes and reduced need for separate antihypertensive medications.
Regulatory agencies may expand methotrexate's approved indications to include hypertension management. Healthcare systems may revise treatment guidelines for RA patients, potentially reducing prescriptions for standalone blood pressure medications. Insurance coverage policies may shift to prioritize methotrexate for eligible RA patients.